Life Sciences Community Advances Toward Next Phase of Innovation at Veeva R&D and Quality Summit
AbbVie, Astellas, Eikon, Merck, Moderna, Roche, and more share new ideas to advance drug development
Veeva R&D and Quality Summit is one of the largest life sciences events, drawing more than 2,000 executives to network and learn across more than 100 sessions.
-
AbbVie and Merck discuss the impact of pharmacovigilance transformation on operational visibility and end-to-end efficiency.
-
Astellas explains its holistic approach to driving end-to-end clinical processes for increased speed and transparency.
-
Eikon Therapeutics highlights the benefits of establishing a foundation for scalable and efficient development from clinical trial to product launch.
-
Neurogene and Verve Therapeutics discuss modernizing quality control with simplified processes and digital-first quality execution.
-
Sanofi showcases leveraging AI-powered translation for faster submission timelines.
- UCB shares its enterprise eCOA journey to accelerate delivery and standardize patient data capture.
"
The event is open exclusively to life sciences professionals. Register and stay up to date on the agenda at veeva.com/Summit.
Additional Information
Register for Veeva R&D and Quality Summit: veeva.com/Summit/register
Connect with
About
Contact:
925-226-8821
deivis.mercado@veeva.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/life-sciences-community-advances-toward-next-phase-of-innovation-at-veeva-rd-and-quality-summit-302220776.html
SOURCE